aluates Reports

$ 0.0

Automative

Oral Antifungal Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-18K13497

Global Oral Antifungal Drugs Market Research Report 2023

BUY CHAPTERS

Oral Antifungal Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-18K13497

Report

October 2024

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Scynexis Inc

Sato Pharmaceutical Co., Ltd.

Mycovia

Oral Antifungal Drugs - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Oral Antifungal Drugs - Market

The global market for Oral Antifungal Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Antifungal Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Oral Antifungal Drugs by region & country, by Type, and by Application.

The Oral Antifungal Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Antifungal Drugs.

Market Segmentation

Scope of Oral Antifungal Drugs - Market Report

Report Metric	Details
Report Name	Oral Antifungal Drugs - Market
CAGR	5%
Segment by Type:	Polyene Antifungal Agents Imidazole Antifungal Agents Triazole Antifungal Agents Others
Segment by Application	Skin Nail Genitals Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Scynexis, Sato Pharmaceutical Co., Ltd., Mycovia, Novartis Pharmaceuticals Corporation
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Oral Antifungal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Oral Antifungal Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Oral Antifungal Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Oral Antifungal Drugs - Market report?

Ans: The main players in the Oral Antifungal Drugs - Market are Scynexis, Sato Pharmaceutical Co., Ltd., Mycovia, Novartis Pharmaceuticals Corporation

What are the Application segmentation covered in the Oral Antifungal Drugs - Market report?

Ans: The Applications covered in the Oral Antifungal Drugs - Market report are Skin, Nail, Genitals, Others

What are the Type segmentation covered in the Oral Antifungal Drugs - Market report?

Ans: The Types covered in the Oral Antifungal Drugs - Market report are Polyene Antifungal Agents, Imidazole Antifungal Agents, Triazole Antifungal Agents, Others

1 Market Overview

1.1 Oral Antifungal Drugs Product Introduction

1.2 Global Oral Antifungal Drugs Market Size Forecast

1.2.1 Global Oral Antifungal Drugs Sales Value (2019-2030)

1.2.2 Global Oral Antifungal Drugs Sales Volume (2019-2030)

1.2.3 Global Oral Antifungal Drugs Sales Price (2019-2030)

1.3 Oral Antifungal Drugs Market Trends & Drivers

1.3.1 Oral Antifungal Drugs Industry Trends

1.3.2 Oral Antifungal Drugs Market Drivers & Opportunity

1.3.3 Oral Antifungal Drugs Market Challenges

1.3.4 Oral Antifungal Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Oral Antifungal Drugs Players Revenue Ranking (2023)

2.2 Global Oral Antifungal Drugs Revenue by Company (2019-2024)

2.3 Global Oral Antifungal Drugs Players Sales Volume Ranking (2023)

2.4 Global Oral Antifungal Drugs Sales Volume by Company Players (2019-2024)

2.5 Global Oral Antifungal Drugs Average Price by Company (2019-2024)

2.6 Key Manufacturers Oral Antifungal Drugs Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Oral Antifungal Drugs Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Oral Antifungal Drugs

2.9 Oral Antifungal Drugs Market Competitive Analysis

2.9.1 Oral Antifungal Drugs Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Oral Antifungal Drugs Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antifungal Drugs as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Polyene Antifungal Agents

3.1.2 Imidazole Antifungal Agents

3.1.3 Triazole Antifungal Agents

3.1.4 Others

3.2 Global Oral Antifungal Drugs Sales Value by Type

3.2.1 Global Oral Antifungal Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Oral Antifungal Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Oral Antifungal Drugs Sales Value, by Type (%) (2019-2030)

3.3 Global Oral Antifungal Drugs Sales Volume by Type

3.3.1 Global Oral Antifungal Drugs Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Oral Antifungal Drugs Sales Volume, by Type (2019-2030)

3.3.3 Global Oral Antifungal Drugs Sales Volume, by Type (%) (2019-2030)

3.4 Global Oral Antifungal Drugs Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Skin

4.1.2 Nail

4.1.3 Genitals

4.1.4 Others

4.2 Global Oral Antifungal Drugs Sales Value by Application

4.2.1 Global Oral Antifungal Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Oral Antifungal Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Oral Antifungal Drugs Sales Value, by Application (%) (2019-2030)

4.3 Global Oral Antifungal Drugs Sales Volume by Application

4.3.1 Global Oral Antifungal Drugs Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Oral Antifungal Drugs Sales Volume, by Application (2019-2030)

4.3.3 Global Oral Antifungal Drugs Sales Volume, by Application (%) (2019-2030)

4.4 Global Oral Antifungal Drugs Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Oral Antifungal Drugs Sales Value by Region

5.1.1 Global Oral Antifungal Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Oral Antifungal Drugs Sales Value by Region (2019-2024)

5.1.3 Global Oral Antifungal Drugs Sales Value by Region (2025-2030)

5.1.4 Global Oral Antifungal Drugs Sales Value by Region (%), (2019-2030)

5.2 Global Oral Antifungal Drugs Sales Volume by Region

5.2.1 Global Oral Antifungal Drugs Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Oral Antifungal Drugs Sales Volume by Region (2019-2024)

5.2.3 Global Oral Antifungal Drugs Sales Volume by Region (2025-2030)

5.2.4 Global Oral Antifungal Drugs Sales Volume by Region (%), (2019-2030)

5.3 Global Oral Antifungal Drugs Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Oral Antifungal Drugs Sales Value, 2019-2030

5.4.2 North America Oral Antifungal Drugs Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Oral Antifungal Drugs Sales Value, 2019-2030

5.5.2 Europe Oral Antifungal Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Oral Antifungal Drugs Sales Value, 2019-2030

5.6.2 Asia Pacific Oral Antifungal Drugs Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Oral Antifungal Drugs Sales Value, 2019-2030

5.7.2 South America Oral Antifungal Drugs Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Oral Antifungal Drugs Sales Value, 2019-2030

5.8.2 Middle East & Africa Oral Antifungal Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Oral Antifungal Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Oral Antifungal Drugs Sales Value

6.2.1 Key Countries/Regions Oral Antifungal Drugs Sales Value, 2019-2030

6.2.2 Key Countries/Regions Oral Antifungal Drugs Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Oral Antifungal Drugs Sales Value, 2019-2030

6.3.2 United States Oral Antifungal Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Oral Antifungal Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Oral Antifungal Drugs Sales Value, 2019-2030

6.4.2 Europe Oral Antifungal Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Oral Antifungal Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Oral Antifungal Drugs Sales Value, 2019-2030

6.5.2 China Oral Antifungal Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Oral Antifungal Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Oral Antifungal Drugs Sales Value, 2019-2030

6.6.2 Japan Oral Antifungal Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Oral Antifungal Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Oral Antifungal Drugs Sales Value, 2019-2030

6.7.2 South Korea Oral Antifungal Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Oral Antifungal Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Oral Antifungal Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Oral Antifungal Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Oral Antifungal Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Oral Antifungal Drugs Sales Value, 2019-2030

6.9.2 India Oral Antifungal Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Oral Antifungal Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Scynexis

7.1.1 Scynexis Company Information

7.1.2 Scynexis Introduction and Business Overview

7.1.3 Scynexis Oral Antifungal Drugs Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Scynexis Oral Antifungal Drugs Product Offerings

7.1.5 Scynexis Recent Development

7.2 Sato Pharmaceutical Co., Ltd.

7.2.1 Sato Pharmaceutical Co., Ltd. Company Information

7.2.2 Sato Pharmaceutical Co., Ltd. Introduction and Business Overview

7.2.3 Sato Pharmaceutical Co., Ltd. Oral Antifungal Drugs Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Sato Pharmaceutical Co., Ltd. Oral Antifungal Drugs Product Offerings

7.2.5 Sato Pharmaceutical Co., Ltd. Recent Development

7.3 Mycovia

7.3.1 Mycovia Company Information

7.3.2 Mycovia Introduction and Business Overview

7.3.3 Mycovia Oral Antifungal Drugs Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Mycovia Oral Antifungal Drugs Product Offerings

7.3.5 Mycovia Recent Development

7.4 Novartis Pharmaceuticals Corporation

7.4.1 Novartis Pharmaceuticals Corporation Company Information

7.4.2 Novartis Pharmaceuticals Corporation Introduction and Business Overview

7.4.3 Novartis Pharmaceuticals Corporation Oral Antifungal Drugs Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Novartis Pharmaceuticals Corporation Oral Antifungal Drugs Product Offerings

7.4.5 Novartis Pharmaceuticals Corporation Recent Development

8 Industry Chain Analysis

8.1 Oral Antifungal Drugs Industrial Chain

8.2 Oral Antifungal Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Oral Antifungal Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Oral Antifungal Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Scynexis Inc

Sato Pharmaceutical Co., Ltd.

Mycovia

List of Tables

Table 1. Oral Antifungal Drugs Market Trends

Table 2. Oral Antifungal Drugs Market Drivers & Opportunity

Table 3. Oral Antifungal Drugs Market Challenges

Table 4. Oral Antifungal Drugs Market Restraints

Table 5. Global Oral Antifungal Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Oral Antifungal Drugs Revenue Market Share by Company (2019-2024)

Table 7. Global Oral Antifungal Drugs Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Oral Antifungal Drugs Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Oral Antifungal Drugs Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Oral Antifungal Drugs Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Oral Antifungal Drugs Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Oral Antifungal Drugs

Table 13. Global Oral Antifungal Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Antifungal Drugs as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Oral Antifungal Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Oral Antifungal Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Oral Antifungal Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Oral Antifungal Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Oral Antifungal Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Oral Antifungal Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Oral Antifungal Drugs Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Oral Antifungal Drugs Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Oral Antifungal Drugs Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Oral Antifungal Drugs Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Oral Antifungal Drugs Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Oral Antifungal Drugs Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Oral Antifungal Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Oral Antifungal Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Oral Antifungal Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Oral Antifungal Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Oral Antifungal Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Oral Antifungal Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Oral Antifungal Drugs Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Oral Antifungal Drugs Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Oral Antifungal Drugs Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Oral Antifungal Drugs Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Oral Antifungal Drugs Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Oral Antifungal Drugs Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Oral Antifungal Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Oral Antifungal Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Oral Antifungal Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Oral Antifungal Drugs Sales Value by Region (2019-2024) & (%)

Table 44. Global Oral Antifungal Drugs Sales Value by Region (2025-2030) & (%)

Table 45. Global Oral Antifungal Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Oral Antifungal Drugs Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Oral Antifungal Drugs Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Oral Antifungal Drugs Sales Volume by Region (2019-2024) & (%)

Table 49. Global Oral Antifungal Drugs Sales Volume by Region (2025-2030) & (%)

Table 50. Global Oral Antifungal Drugs Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Oral Antifungal Drugs Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Oral Antifungal Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Oral Antifungal Drugs Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Oral Antifungal Drugs Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Oral Antifungal Drugs Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Oral Antifungal Drugs Sales Volume, (2025-2030) & (K Units)

Table 57. Scynexis Company Information

Table 58. Scynexis Introduction and Business Overview

Table 59. Scynexis Oral Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Scynexis Oral Antifungal Drugs Product Offerings

Table 61. Scynexis Recent Development

Table 62. Sato Pharmaceutical Co., Ltd. Company Information

Table 63. Sato Pharmaceutical Co., Ltd. Introduction and Business Overview

Table 64. Sato Pharmaceutical Co., Ltd. Oral Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Sato Pharmaceutical Co., Ltd. Oral Antifungal Drugs Product Offerings

Table 66. Sato Pharmaceutical Co., Ltd. Recent Development

Table 67. Mycovia Company Information

Table 68. Mycovia Introduction and Business Overview

Table 69. Mycovia Oral Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Mycovia Oral Antifungal Drugs Product Offerings

Table 71. Mycovia Recent Development

Table 72. Novartis Pharmaceuticals Corporation Company Information

Table 73. Novartis Pharmaceuticals Corporation Introduction and Business Overview

Table 74. Novartis Pharmaceuticals Corporation Oral Antifungal Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Novartis Pharmaceuticals Corporation Oral Antifungal Drugs Product Offerings

Table 76. Novartis Pharmaceuticals Corporation Recent Development

Table 77. Key Raw Materials Lists

Table 78. Raw Materials Key Suppliers Lists

Table 79. Oral Antifungal Drugs Downstream Customers

Table 80. Oral Antifungal Drugs Distributors List

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

List of Figures

Figure 1. Oral Antifungal Drugs Product Picture

Figure 2. Global Oral Antifungal Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Oral Antifungal Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Oral Antifungal Drugs Sales Volume (2019-2030) & (K Units)

Figure 5. Global Oral Antifungal Drugs Sales Price (2019-2030) & (US$/Unit)

Figure 6. Oral Antifungal Drugs Report Years Considered

Figure 7. Global Oral Antifungal Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Oral Antifungal Drugs Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Antifungal Drugs Revenue in 2023

Figure 10. Oral Antifungal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Polyene Antifungal Agents Picture

Figure 12. Imidazole Antifungal Agents Picture

Figure 13. Triazole Antifungal Agents Picture

Figure 14. Others Picture

Figure 15. Global Oral Antifungal Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Oral Antifungal Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Oral Antifungal Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 18. Global Oral Antifungal Drugs Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Oral Antifungal Drugs Price by Type (2019-2030) & (US$/Unit)

Figure 20. Product Picture of Skin

Figure 21. Product Picture of Nail

Figure 22. Product Picture of Genitals

Figure 23. Product Picture of Others

Figure 24. Global Oral Antifungal Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global Oral Antifungal Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 26. Global Oral Antifungal Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 27. Global Oral Antifungal Drugs Sales Volume Market Share by Application, 2023 & 2030

Figure 28. Global Oral Antifungal Drugs Price by Application (2019-2030) & (US$/Unit)

Figure 29. North America Oral Antifungal Drugs Sales Value (2019-2030) & (US$ Million)

Figure 30. North America Oral Antifungal Drugs Sales Value by Country (%), 2023 VS 2030

Figure 31. Europe Oral Antifungal Drugs Sales Value (2019-2030) & (US$ Million)

Figure 32. Europe Oral Antifungal Drugs Sales Value by Country (%), 2023 VS 2030

Figure 33. Asia Pacific Oral Antifungal Drugs Sales Value (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Oral Antifungal Drugs Sales Value by Country (%), 2023 VS 2030

Figure 35. South America Oral Antifungal Drugs Sales Value (2019-2030) & (US$ Million)

Figure 36. South America Oral Antifungal Drugs Sales Value by Country (%), 2023 VS 2030

Figure 37. Middle East & Africa Oral Antifungal Drugs Sales Value (2019-2030) & (US$ Million)

Figure 38. Middle East & Africa Oral Antifungal Drugs Sales Value by Country (%), 2023 VS 2030

Figure 39. Key Countries/Regions Oral Antifungal Drugs Sales Value (%), (2019-2030)

Figure 40. Key Countries/Regions Oral Antifungal Drugs Sales Volume (%), (2019-2030)

Figure 41. United States Oral Antifungal Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 42. United States Oral Antifungal Drugs Sales Value by Type (%), 2023 VS 2030

Figure 43. United States Oral Antifungal Drugs Sales Value by Application (%), 2023 VS 2030

Figure 44. Europe Oral Antifungal Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 45. Europe Oral Antifungal Drugs Sales Value by Type (%), 2023 VS 2030

Figure 46. Europe Oral Antifungal Drugs Sales Value by Application (%), 2023 VS 2030

Figure 47. China Oral Antifungal Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 48. China Oral Antifungal Drugs Sales Value by Type (%), 2023 VS 2030

Figure 49. China Oral Antifungal Drugs Sales Value by Application (%), 2023 VS 2030

Figure 50. Japan Oral Antifungal Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 51. Japan Oral Antifungal Drugs Sales Value by Type (%), 2023 VS 2030

Figure 52. Japan Oral Antifungal Drugs Sales Value by Application (%), 2023 VS 2030

Figure 53. South Korea Oral Antifungal Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 54. South Korea Oral Antifungal Drugs Sales Value by Type (%), 2023 VS 2030

Figure 55. South Korea Oral Antifungal Drugs Sales Value by Application (%), 2023 VS 2030

Figure 56. Southeast Asia Oral Antifungal Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 57. Southeast Asia Oral Antifungal Drugs Sales Value by Type (%), 2023 VS 2030

Figure 58. Southeast Asia Oral Antifungal Drugs Sales Value by Application (%), 2023 VS 2030

Figure 59. India Oral Antifungal Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 60. India Oral Antifungal Drugs Sales Value by Type (%), 2023 VS 2030

Figure 61. India Oral Antifungal Drugs Sales Value by Application (%), 2023 VS 2030

Figure 62. Oral Antifungal Drugs Industrial Chain

Figure 63. Oral Antifungal Drugs Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions